News in the Life Sciences Industry

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS... Read more ››

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS... Read more ››

STOCKHOLM, June 4, 2020 /PRNewswire/ -- IRLAB's clinical Phase IIb/III study with the drug candidate mesdopetam (IRL790) in development for the treatment of levodopa induced dyskinesia (LIDs) in Parkinson's disease, will have a study design with the following main points:

STOCKHOLM, June 4, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company... Read more ››

GOTHENBURG, Sweden, June 3, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL) ("Isofol" or the "Company") fully guaranteed new share issue with preferential rights for the Company's existing shareholders (the "Rights Issue"), which ended on... Read more ››

LINKÖPING, Sweden, June 3, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT... Read more ››

STOCKHOLM, June 3, 2020 /PRNewswire/ -- A British study initiated by researchers in which endurance athletes used Enzymatica's ColdZyme®(®) cold spray shows significantly shorter duration of common colds and milder common cold symptoms compared with endurance athletes in the untreated group.... Read more ››

STOCKHOLM, June 2, 2020 /PRNewswire/ -- Reference is made to the extraordinary general meeting notice published on 20(th) of May 2020 regarding a repair issue with gross proceeds of up to NOK 9 million directed towards eligible shareholders and company employees (the "Repair Issue"). The Repair... Read more ››

STOCKHOLM, June 3, 2020 /PRNewswire/ -- The effect of Hydrocyn® aqua (Hydrocyn) on the new coronavirus (SARS-CoV-2) causing COVID-19 has been confirmed. Tests performed by the Swedish National Veterinary Institute show that 99.9% of the virus particles were killed after exposure to Hydrocyn.... Read more ››

STOCKHOLM, June 1, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ) will today launch an investor roadshow for a contemplated initial public offering of American Depositary Shares in the United States for trading on The Nasdaq Global Market in the United States and a concurrent private... Read more ››

LUND, Sweden, June 1, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the company received an additional USD 0.5 million in a second installment of the upfront payment from the Chinese company Biotheus Inc. A first installment of USD 0.5 million... Read more ››

STOCKHOLM, June 1, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces that patients in the OCEAN study stay on treatment longer than previously estimated. As a consequence, top-line results are estimated for H1 2021 instead of previously communicated Q4 2020. Patient... Read more ››